health pharma news today obesity drugs glp-1 Drugmaker Eli Lilly announced that the FDA approved its daily pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. , India Tightens Oversight on GLP-1

The underlying biochemistry is real

The study included a survey with 1,955 useable observations including 495 people who were currently taking a GLP-1, 468 who had previously taken one, 492 people who were planning to take one, and 500 people who were neither taking one nor planning to take one

To reference wikipedia, research began in the early 1960s which showed that in rats, administration of -MSH caused sexual arousal

5.3 Bacteriotherapies The issues inherent to pharmacological- and immunological-based approaches has necessitated the exploration of alternative therapies against NTHi infections

Natarajan V, Ganju P, Ramkumar A, et al